XORTX Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:XRTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Mar 24	BuyUS$7,091	Anthony Giovinazzo	Individual	1,525	US$4.65
15 Feb 24	BuyUS$22,208	Allen Davidoff	Individual	10,000	US$2.22
27 Dec 23	BuyUS$1,316	Anthony Giovinazzo	Individual	600	US$2.19
13 Dec 23	BuyUS$5,593	Allen Davidoff	Individual	3,000	US$1.86
13 Dec 23	BuyUS$18,912	Anthony Giovinazzo	Individual	7,500	US$2.52
01 Dec 23	BuyUS$7,265	Allen Davidoff	Individual	3,000	US$2.42

Insider Buying: XRTX insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.3%.

Top 11 shareholders own 13.5% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.86%	Armistice Capital LLC	169,790	US$419.4k	0%	0.01%
3.75%	Prevail Partners	108,591	US$268.2k	0%	no data
2.34%	Allen Davidoff	67,957	US$167.9k	17.3%	no data
0.52%	BMO Asset Management Corp.	14,994	US$37.0k	0%	no data
0.33%	Anthony Giovinazzo	9,625	US$23.8k	18.8%	no data
0.25%	Paul Van Damme	7,110	US$17.6k	0%	no data
0.24%	James Fairbairn	6,946	US$17.2k	0%	no data
0.16%	Ian Klassen	4,751	US$11.7k	0%	no data
0.04%	Osaic Wealth, Inc. , Asset Management Arm	1,153	US$2.8k	0%	no data
0.0096%	Clearstead Advisors, LLC	277	US$684.5	0%	no data
0.0088%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	254	US$627.2	0%	no data